Loading company…
SOCIUM Inc., a Tokyo pharmaceutical research firm founded in 2017, offers drug discovery services such as phosphorylation analysis.
Founded in 2017 and based in Tokyo, Japan, SOCIUM Inc. provides drug discovery and analytical services to biotechnology and pharmaceutical companies in North America, Asia and Europe. Its offerings include phosphorylation analysis and consulting, and it works with Nanjing Medical University and Huaxi Hospital of Sichuan University on amyotrophic lateral sclerosis (ALS) research. Revenue comes from project-based contract research. In July 2021 the company raised JPY 10 million in Series B funding from the National Institute of Advanced Industrial Science and Technology. Its current valuation is JPY 1,980.426 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in